The Elizabeth Holmes trial: Fraud, funding and a reckoning for Silicon Valley
But, from 2003 — when she first founded her company Theranos — all the way to 2013, she built a company valued at $10 billion.
But, not everyone was convinced.
“I met Elizabeth Holmes late in 2006, when she was raising some of the early rounds of capital for Theranos, and it was clear when I sat across the room from her that she could not answer the basic questions about how the device worked,” Dr. Bijan Salehizadeh says.
If that’s the case, why did so many other supposedly savvy investors fall for her?
“What we’re seeing in the last decade-plus with a lot of companies led by these young, charismatic founders that are attracting vast amounts of capital is, the story is the vast amounts of capital,” Margaret O’Mara says.
Today, On Point: Fraud, funding and Silicon Valley’s ‘fake it till you make it’ culture.
Dr. Bijan Salehizadeh, investor in health care venture capital and private equity for over 20 years. (@bijans)
Micah Rosenbloom, managing partner at the venture capital firm Founder Collective. (@micahjay1)
Margaret O’Mara, professor of history at the University of Washington. Author of “The Code: Silicon Valley and the Remaking of America.”
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.